Intraocular injection of tamoxifen-loaded nanoparticles: A new treatment of experimental autoimmune uveoretinitis

European Journal of Immunology

Volumn 34, Issue 12, 2004, Pages 3702-3712

  de Kozak, Yvonne ^a   Andrieux, Karine ^b   Villarroya, Henri ^a   Klein, Christophe ^c   Thillaye Goldenberg, Brigitte ^a   Naud, Marie Christine ^a   Garcia, Elisabeth ^b   Couvreur, Patrick ^b  

^a INSERM   (France)

^b UNIV PARIS SUD   (France)

^c IFR 58   (France)

Author keywords

Drug delivery; Experimental autoimmune uveoretinitis; Nanoparticles; Tamoxifen; Treatment

Indexed keywords

ESTRADIOL; FLUORESCENT DYE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 1BETA; LYMPHOCYTE ANTIGEN; MACROGOL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NANOPARTICLE; RANTES; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DRUG BIOAVAILABILITY; DRUG COATING; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; GENE REARRANGEMENT; IMMUNE RESPONSE; INFLAMMATORY CELL; INGUINAL LYMPH NODE; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MACROPHAGE MIGRATION; MALE; MEDICAL DECISION MAKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TH1 CELL; TREATMENT OUTCOME; UVEORETINITIS;

EID: 10944223807     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425022     Document Type: Article

References (38)

1. Caspi, R. R., Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int. Rev. Immunol 2002. 21: 197-208.
2. Pouvreau, I., Zech, J. C., Thillaye-Goldenberg, B., Naud, M.-C., Van Rooijen, N. and de Kozak, Y., Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. J. Neuroimmunol. 1998. 86: 171-181.
3. Forrester, J. V., Huitinga, I., Lumsden, L. and Dijkstra, C. D., Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr. Eye Res 1998. 17: 426-437.
4. Luna, J. D., Chan, C. C., Derevjanik, N. L., Mahlow, J., Chiu, C., Peng, B., Tobe, T., Campochiaro, P. A. and Vinores, S. A., Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J. Neurosci. Res 1997. 49: 268-280.
5. Nussenblatt, R. B. and Gery, I., Experimental autoimmune uveitis and its relationship to clinical ocular inflammatory disease. J. Autoimmun 1996. 9: 575-585.
6. Dick, A. D., Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Int. Ophthalmol. Clin 2000. 40: 1-18.
7. de Kozak, Y. and Verwaerde, C., Cytokines in immunotherapy of experimental uveitis. Int. Rev. Immunol. 2002. 21: 231-253.
8. De Kozak, Y., Thillaye-Goldenberg, B., Naud, M.-C., Da Costa, A. V., Auriault, C. and Verwaerde, C., Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene. Clin. Exp. Immunol 2002. 130: 212-223.
9. Verwaerde, C., Naud, M.-C., Delanoye, A., Wood, M., Thillaye-Goldenberg, B., Auriault, C. and de Kozak, Y., Ocular transfer of retinal glial cells transduced ex vivo with adenovirus expressing viral IL-10 or CTLA4-Ig inhibits experimental autoimmune uveoretinitis. Gene Ther. 2003. 10: 1970-1981.
10. Grainger, D. J. and Metcalfe, J. C., Tamoxifen: teaching an old drug new tricks? Nat. Med. 1996. 2: 381-385.
11. Jordan, V. C., Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents. J. Med. Chem 2003. 46: 1081-1111.
12. Dayan, M., Zinger, H., Kalush, F., Mor, G., Amir-Zaltzman, Y., Kohen, F., Sthoeger, Z. and Mozes, E., The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology. 1997. 90: 101-108.
13. Wiseman, H., Tamoxifen: new membrane-mediated mechanisms of action and therapeutic advances. Trends Pharmacol. Sci 1994. 15: 83-89.
14. Komi, J. and Lassila, O., Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000. 95: 2875-2882.
15. van Leeuwen, F. E., Benraadt, J., Coebergh, J. W., Kiemeney, L. A., Gimbrere, C. H., Otter, R., Schouten, L. J., Damhuis, R. A., Bontenbal, M., Diepenhorst, F. W. et al., Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 1994. 343: 448-452.
16. Lazzaroni, F., Scorolli, L., Pizzoleo, C. F., Savini, G., De Nigris, A., Giosa, F. and Meduri, R. A., Tamoxifen retinopathy: does it really exist? Graefes Arch. Clin. Exp. Ophthalmol. 1998. 236: 669-673.
17. Peracchia, M. T., Vauthier, C., Desmaele, D., Gulik, A., Dedieu, J. C., Demoy, M., d'Angelo, J. and Couvreur, P., Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoa-crylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm. Res 1998. 4: 550-556.
18. Brigger, I., Chaminade, P., Marsaud, V., Appel, M., Besnard, M., Gurny, R., Renoir, M. and Couvreur, P., Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestrogen formulation. Int. J. Pharm 2001. 214: 37-42.
19. Jansson, L. and Holmdahl, R., Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum. 2001. 44: 2168-2175.
20. Bebo, B. F. Jr., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A. and Offner, H., Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 2001. 166: 2080-2089.
21. Bourges, J. L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J. C., Gurny, R., BenEzra, D. and Behar-Cohen, F. F., Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 2003. 44: 3562-3569.
22. Moghimi, S. M., Hunter, A. C. and Murray, J. C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev 2001. 53: 283-318.
23. Muller, R. H., Jacobs, C. and Kayser, O., Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev 2001. 47: 3-19.
24. Whitacre, C. C., Reingold, S. C. and O'Looney, P. A., A gender gap in autoimmunity. Science 1999. 283: 1277-1278.
25. Maret, A., Coudert, J. D., Garidou, L., Foucras, G., Gourdy, P., Krust, A., Dupont, S., Chambon, P., Druet, P., Bayard, F. and Guery, J. C., Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J. Immunol 2003. 33: 512-521.
26. Subramanian, S., Matejuk, A., Zamora, A., Vandenbark, A. A. and Offner, H., Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J. Immunol. 2003. 170: 1548-1555.
27. Badger, A. M., Blake, S. M., Dodds, R. A., Griswold, D. E., Swift, B. A., Rieman, D. J., Stroup, G. B., Hoffman, S. J. and Gowen, M., Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis. J. Pharmacol. Exp. Ther. 1999. 291: 1380-1386.
28. Miyamoto, N., Mandai, M., Suzuma, I., Suzuma, K., Kobayashi, K. and Honda, Y., Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J. Immunol. 1999. 163: 374-379.
29. Crane, I. J., McKillop-Smith, S., Wallace, C. A., Lamont, G. R. and Forrester, J. V., Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2001. 7: 1547-1552.
30. Agarwal, R. K., Chan, C. C., Wiggert, B. and Caspi, R. R., Pregnancy ameliorates induction and expression of experimental autoimmune uveitis. J. Immunol. 1999. 162: 2648-2654.
31. Camelo, S., Shanley, A., Voon, A. S. and McMenamin, R G., The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye. J. Immunol 2004. 172: 5388-5395.
32. Dullforce, P. A., Garman, K. L., Seitz, G. W., Fleischmann, R. J., Crespo, S. M., Planck, S. R., Parker, D. C. and Rosenbaum, J. T., APCs in the anterior uveal tract do not migrate to draining lymph nodes. J. Immunol. 2004. 172: 6701-6708.
33. Stein-Streilein, J. and Streilein, J. W., Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int. Rev. Immunol. 2002. 21: 123-152.
34. Munaut, C., Lambert, V., Noel, A., Frankenne, F., Deprez, M., Foidart, J. M. and Rakic, J. M., Presence of oestrogen receptor type beta in human retina. Br. J. Ophthalmol. 2001. 85: 877-882.
35. Gulshan, S., McCruden, A. B. and Stimson, W. H., Oestrogen receptors in macrophages. Scand. J. Immunol. 1990. 6: 691-697.
36. Cohen, J. H., Danel, L., Cordier, G., Saez, S. and Revillard, J. P., Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J. Immunol. 1983. 131: 2767-2771.
37. Ramanathan, S., de Kozak, Y., Saoudi, A., Goureau, O., Van der Meide, P. H., Druet, P. and Bellon, B., Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats. J. Immunol. 1996. 157: 2209-2215.
38. Thillaye-Goldenberg, B., Goureau, O., Naud, M.-C. and de Kozak, Y., Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2. J. Neuroimmunol 2000. 110: 31-44.